CIK 0001822462 · Non-accelerated filer<br>Smaller reporting company
Foghorn Therapeutics Inc.
Sign in to watch- Ticker
- FHTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-586-3100
- Business address
- 500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −63,000 | 0 | ||
| 2023-08-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +63,000 | 511,704 | ||
| 2023-08-16 | Agresta Samuel Chief Medical Officer | Option exercise | +311,297 | $3.72 | $1.2M | 311,297 |
| 2023-08-16 | Agresta Samuel Chief Medical Officer | Sale | −311,297 | $8.25 | $2.6M | 0 |
| 2023-08-16 | Agresta Samuel Chief Medical Officer | Option exercise · Stock Option (right to buy) | −311,297 | 0 | ||
| 2023-06-21 | PARSHALL B LYNNE Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | Lynch Thomas J. Jr. Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | Cole Douglas G. Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | SMITH IAN F Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | Biller Scott Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | Koppel Adam Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | GILL SIMBA Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-06-21 | Mendelsohn Michael Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 | ||
| 2023-05-26 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −300,000 | 448,704 | ||
| 2023-05-26 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +300,000 | 448,704 | ||
| 2023-02-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | −4,371 | 63,000 | ||
| 2023-02-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Gift | +4,371 | 448,704 | ||
| 2023-02-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Other disposition | −184,939 | 448,704 | ||
| 2023-02-17 | GOTTSCHALK ADRIAN Chief Executive Officer | Other acquisition | +184,939 | 448,704 | ||
| 2023-01-26 | Agresta Samuel Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 |
Page 5 of 9 · 177 trades